Aclaris Therapeutics, Inc. (LON:0H8T)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.135
-0.014 (-1.25%)
At close: Apr 16, 2025

Aclaris Therapeutics Market Cap

Aclaris Therapeutics has a market cap or net worth of 96.69 million as of April 24, 2025. Its market cap has increased by 44.92% in one year.

Market Cap
96.69M
Enterprise Value
-54.87M
Revenue
14.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.14

Market Cap Chart

Since October 7, 2015, Aclaris Therapeutics's market cap has decreased from 140.05M to 96.69M, a decrease of -30.96%. That is a compound annual growth rate of -3.81%.

History

DateMarket Cap% Change
Apr 23, 202596.69M-54.39%
Dec 31, 2024212.00M263.06%
Dec 29, 202358.39M-93.30%
Dec 30, 2022871.66M32.58%
Dec 31, 2021657.46M223.25%
Dec 31, 2020203.39M244.36%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 157.23B
GSK plc 55.19B
Haleon 34.87B
Smith & Nephew 8.58B
ConvaTec Group 5.21B
Hikma Pharmaceuticals 4.15B
HUTCHMED (China) 2.01B
Oxford Nanopore Technologies 1.13B
Market Cap Rankings